SOUTHPOINTE, Pa.--(BUSINESS WIRE)--ANSYS, Inc. (NASDAQ: ANSS), a global innovator of simulation software and technologies designed to optimize product development processes, today announced its participation in the Osteoporotic Virtual Physiological Human Project (VPHOP), launched this fall by a European consortium. VPHOP aims to develop a new generation of medical technologies designed to predict the patient-specific risk of osteoporosis and bone fracture, improving diagnosis and treatment as well. Software from ANSYS is being used to simulate the variety of structural and fluid flow dynamics within the human anatomy based on the project’s collection of anatomical, physiological and pathological data.
